




版權說明:本文檔由用戶提供并上傳,收益歸屬內容提供方,若內容存在侵權,請進行舉報或認領
文檔簡介
AcuteRenalReplacementTherapyfortheInfantDr.FahadGadi,MDPediatricsDemonstratorKingAbdulazizUniversityRabighMedicalSchoolAcuteRenalReplacementTherapObjectivesIndicationsandgoalsforacuterenalreplacementtherapyModalitiesforrenalreplacementtherapyPeritonealdialysisIntermittenthemodialysisContinuousrenalreplacementtherapy(CRRT)SpecialissuesrelatedtotheinfantObjectivesIndicationsandgoalIndicationsforRenalReplacementVolumeoverloadMetabolicimbalanceToxins(endogenousorexogenous)InabilitytoprovideneededdailyfluidsduetoinsufficienturinaryexcretionIndicationsforRenalReplacemGoalsofRenalReplacementRestorefluid,electrolyteandmetabolicbalanceRemoveendogenousorexogenoustoxinsasrapidlyaspossiblePermitneededtherapyandnutritionLimitcomplicationsGoalsofRenalReplacementRestRenalReplacementfortheInfant:
ASetofSpecialChallengesSmallsizeofthepatientEquipmentdesignedforlargerpeopleSmallbloodvolumewillmagnifyeffectsofanyerrorsAchievingaccessmaybedifficultStaffmayhaveinfrequentexperienceRenalReplacementfortheInfaModalitiesforRenalReplacementPeritonealdialysisIntermittenthemodialysisContinuousrenalreplacementtherapy(CRRT)ModalitiesforRenalReplacemeModalitiesforRenalReplacementPeritonealdialysisIntermittenthemodialysisContinuousrenalreplacementtherapy(CRRT)ModalitiesforRenalReplacemePD:ConsiderationsforInfantsADVANTAGESExperienceinthechronicsettingNovascularaccessNoextracorporealperfusionSimplicity?Preferredmodalityforcardiacpatients?DISADVANTAGESInfectiousriskLeak?Respiratorycompromise?SodiumsievingDeadspaceintubingPD:ConsiderationsforInfantsModalitiesforRenalReplacementPeritonealdialysisIntermittenthemodialysisContinuousrenalreplacementtherapy(CRRT)ModalitiesforRenalReplacemeIHD:ConsiderationsforInfantsADVANTAGESRapidparticleandfluidremoval;mostefficientmodalityDoesnotrequireanticoagulation24h/dDISADVANTAGESVascularaccessComplicatedLargeextracorporealvolumeAdaptedequipment?PoorlytoleratedIHD:ConsiderationsforInfantModalitiesforRenalReplacementPeritonealdialysisIntermittenthemodialysisContinuousrenalreplacementtherapy(CRRT)ModalitiesforRenalReplacemeCRRTforInfants:
ASeriesofChallengesSmallpatientwithsmallbloodvolumeEquipmentdesignedforbiggerpeopleNospecificprotocolsComplicationsmaybemagnifiedNoclearguidelinesLimitedoutcomedataCRRTforInfants:
ASeriesofPotentialComplicationsofInfantCRRTVolumerelatedproblemsBiochemicalandnutritionalproblemsHemorrhage,infectionThermiclossTechnicalproblemsLogisticalproblemsPotentialComplicationsofInfCRRTinInfants<10Kg:OutcomePatients<10kgPatients3-10kgPatients<3kg38%Survival41%Survival25%SurvivalAmJKidDis,18:833-837,2003CRRTinInfants<10Kg:OutcomeppCRRTDataofInfants<10Kg:DemographicInformationNumberofSubjects84 (51boys(61%)) (33girls(39%))AgeMedian69days (1d-2.9y)ICUAdmitweightMedian4.4kg (1.3-10kg)ppCRRTDataofInfants<10Kg:ppCRRTDataofInfants<10Kg:PrimaryDiagnosesppCRRTDataofInfants<10Kg:ppCRRTDataofInfants<10Kg:IndicationsforCRRTFluidOverloadandElectrolyteImbalance84%Other(EndogenousToxinRemoval)16%N=84ppCRRTDataofInfants<10Kg:ppCRRTDataofInfants<10Kg:ClinicalDataParameterMedianRangeDaysinICUpriortoCRRT20-135PRISMscore—ICUadmit17.50-48PRISMscore—CRRTstart200-48Inotropenumber—CRRTstart10-4Urineoutput—CRRTstart(ml/kg/hroverprior24hrs)0.70-12%FluidoverloadfromICUadmissiontoCRRTstart13.7-28-220ppCRRTDataofInfants<10Kg:ppCRRTDataofInfants<10Kg:TechnicalCharacteristicsofCRRTCatheterSiteFemoral60%InternalJugular28%Subclavian12%ModalityCVVHD59%CVVH18%CVVHDF23%AnticoagulationCitrate55%Heparin45%PrimeBlood87%Saline8%Albumin5%N=84ppCRRTDataofInfants<10Kg:ppCRRTDataofInfants<10Kg:CRRTTreatmentDataN=84ParameterMedianRangeBloodFlow(ml/kg/min)81.7-46FluidFlow(ml/kg/hour)677-571AverageCRRTClearance(ml/hr/1.73M2)2582135-19319AggregateCRRTClearance(ml/hr/1.73M2)3540135-12713CRRTduration(days)50-83ppCRRTDataofInfants<10Kg:ppCRRTDataofInfants<10Kg:SurvivalbyWeight44%42%43%64%p=0.001p=1.0ppCRRTDataofInfants<10Kg:ppCRRTDataofInfants<10Kg:FactorsEffectingSurvivalClinicalVariableSurvivorsNon-SurvivorsPAdmissionPRISMscore1621<0.05GI/Hepaticdisease8%31%0.01Multiorgandysfunction68%91%0.04PressorDependency36%69%<0.01MeanAirwayPressure1120<0.001Initialurineoutput(ml/kg/hr)2.41.00.02%FluidOverloadatStart15%34%0.02>10%OverloadatStart43%71%0.02ppCRRTDataofInfants<10Kg:PRISMADedicatedCRRTdeviceHighlyautomatedDesignedforeaseofuseatthebedsidePRISMADedicatedCRRTdeviceBradykininReleaseSyndromeMucosalcongestion,bronchospasm,hypotensionatstartofCRRTResolveswithdiscontinuationofCRRTThoughttoberelatedtobradykininreleasewhenpatient’sbloodcontactshemofilterExquisitelypHsensitiveBradykininReleaseSyndromeMucBypassSystemtoPreventBradykininReleaseSyndromePRBCWasteBypassSystemtoPreventBradyRecirculationSystemtoPreventBradykininReleaseSyndromeDWasteRecirculationPlan:Qb200ml/minQd~40ml/minTime7.5minNormalizepHNormalizeK+RecirculationSystemtoPrevenAcuteInitiationChecklist:ExampleInfantICUNurseTimeZero:MovepttoroomwithdialysiswaterGetordersfromresidentforIVfluidstokeepaccessopen20–40min:MeetMD;discussRRTplan60–120min:MeetICUteamDialysisNurse10–60min:Arriveandbeginsetup20–40min:MeetMD;discussRRTplan60–120min:Completeprime;readyforaccessBeginRRTMeetICUteamAcuteInitiationChecklist:ExAcuteInitiationChecklist:ExampleNephrologyMDTimeZero:ContactdialysisnursetostartRRTurgently10–20min:BringcatheterstoICUEnterordersforRRT20–40min:MeetICUMDs&RNs,discussplan60–120min:PresentinICUforinitiationMeetICUteamIVAccessMD10–30min:Arriveandbegininsertionofdialysisaccess60min(orwhencircuitisreadyforRx)CompleteinsertionofaccessConnectportstoheparinIVsolutionsAcuteInitiationChecklist:ExInfantRRT:SummaryAllmodalitiesofRRTpossibleforinfantsNomodalityisperfectTechnicalchallengescanbemetCarefulplanningwithinstitution,program,andindividualsimprovescareCooperation,communication,andcollaborationwillincreaseoursuccessInfantRRT:SummaryAllmodalitThanks!Thanks!AcuteRenalReplacementTherapyfortheInfantDr.FahadGadi,MDPediatricsDemonstratorKingAbdulazizUniversityRabighMedicalSchoolAcuteRenalReplacementTherapObjectivesIndicationsandgoalsforacuterenalreplacementtherapyModalitiesforrenalreplacementtherapyPeritonealdialysisIntermittenthemodialysisContinuousrenalreplacementtherapy(CRRT)SpecialissuesrelatedtotheinfantObjectivesIndicationsandgoalIndicationsforRenalReplacementVolumeoverloadMetabolicimbalanceToxins(endogenousorexogenous)InabilitytoprovideneededdailyfluidsduetoinsufficienturinaryexcretionIndicationsforRenalReplacemGoalsofRenalReplacementRestorefluid,electrolyteandmetabolicbalanceRemoveendogenousorexogenoustoxinsasrapidlyaspossiblePermitneededtherapyandnutritionLimitcomplicationsGoalsofRenalReplacementRestRenalReplacementfortheInfant:
ASetofSpecialChallengesSmallsizeofthepatientEquipmentdesignedforlargerpeopleSmallbloodvolumewillmagnifyeffectsofanyerrorsAchievingaccessmaybedifficultStaffmayhaveinfrequentexperienceRenalReplacementfortheInfaModalitiesforRenalReplacementPeritonealdialysisIntermittenthemodialysisContinuousrenalreplacementtherapy(CRRT)ModalitiesforRenalReplacemeModalitiesforRenalReplacementPeritonealdialysisIntermittenthemodialysisContinuousrenalreplacementtherapy(CRRT)ModalitiesforRenalReplacemePD:ConsiderationsforInfantsADVANTAGESExperienceinthechronicsettingNovascularaccessNoextracorporealperfusionSimplicity?Preferredmodalityforcardiacpatients?DISADVANTAGESInfectiousriskLeak?Respiratorycompromise?SodiumsievingDeadspaceintubingPD:ConsiderationsforInfantsModalitiesforRenalReplacementPeritonealdialysisIntermittenthemodialysisContinuousrenalreplacementtherapy(CRRT)ModalitiesforRenalReplacemeIHD:ConsiderationsforInfantsADVANTAGESRapidparticleandfluidremoval;mostefficientmodalityDoesnotrequireanticoagulation24h/dDISADVANTAGESVascularaccessComplicatedLargeextracorporealvolumeAdaptedequipment?PoorlytoleratedIHD:ConsiderationsforInfantModalitiesforRenalReplacementPeritonealdialysisIntermittenthemodialysisContinuousrenalreplacementtherapy(CRRT)ModalitiesforRenalReplacemeCRRTforInfants:
ASeriesofChallengesSmallpatientwithsmallbloodvolumeEquipmentdesignedforbiggerpeopleNospecificprotocolsComplicationsmaybemagnifiedNoclearguidelinesLimitedoutcomedataCRRTforInfants:
ASeriesofPotentialComplicationsofInfantCRRTVolumerelatedproblemsBiochemicalandnutritionalproblemsHemorrhage,infectionThermiclossTechnicalproblemsLogisticalproblemsPotentialComplicationsofInfCRRTinInfants<10Kg:OutcomePatients<10kgPatients3-10kgPatients<3kg38%Survival41%Survival25%SurvivalAmJKidDis,18:833-837,2003CRRTinInfants<10Kg:OutcomeppCRRTDataofInfants<10Kg:DemographicInformationNumberofSubjects84 (51boys(61%)) (33girls(39%))AgeMedian69days (1d-2.9y)ICUAdmitweightMedian4.4kg (1.3-10kg)ppCRRTDataofInfants<10Kg:ppCRRTDataofInfants<10Kg:PrimaryDiagnosesppCRRTDataofInfants<10Kg:ppCRRTDataofInfants<10Kg:IndicationsforCRRTFluidOverloadandElectrolyteImbalance84%Other(EndogenousToxinRemoval)16%N=84ppCRRTDataofInfants<10Kg:ppCRRTDataofInfants<10Kg:ClinicalDataParameterMedianRangeDaysinICUpriortoCRRT20-135PRISMscore—ICUadmit17.50-48PRISMscore—CRRTstart200-48Inotropenumber—CRRTstart10-4Urineoutput—CRRTstart(ml/kg/hroverprior24hrs)0.70-12%FluidoverloadfromICUadmissiontoCRRTstart13.7-28-220ppCRRTDataofInfants<10Kg:ppCRRTDataofInfants<10Kg:TechnicalCharacteristicsofCRRTCatheterSiteFemoral60%InternalJugular28%Subclavian12%ModalityCVVHD59%CVVH18%CVVHDF23%AnticoagulationCitrate55%Heparin45%PrimeBlood87%Saline8%Albumin5%N=84ppCRRTDataofInfants<10Kg:ppCRRTDataofInfants<10Kg:CRRTTreatmentDataN=84ParameterMedianRangeBloodFlow(ml/kg/min)81.7-46FluidFlow(ml/kg/hour)677-571AverageCRRTClearance(ml/hr/1.73M2)2582135-19319AggregateCRRTClearance(ml/hr/1.73M2)3540135-12713CRRTduration(days)50-83ppCRRTDataofInfants<10Kg:ppCRRTDataofInfants<10Kg:SurvivalbyWeight44%42%43%64%p=0.001p=1.0ppCRRTDataofInfants<10Kg:ppCRRTDataofInfants<10Kg:FactorsEffectingSurvivalClinicalVariableSurvivorsNon-SurvivorsPAdmissionPRISMscore1621<0.05GI/Hepaticdisease8%31%0.01Multiorgandysfunction68%91%0.04PressorDependency36%69%<0.01MeanAirwayPressure1120<0.001Initialurineoutput(ml/kg/hr)2.41.00.02%FluidOverloadatStart15%34%0.02>10%OverloadatStart43%71%0.02ppCRRTDataofInfants<10Kg:PRISMADedicatedCRRTdeviceHighlyautomatedDesignedforeaseofuseatthebedsidePRISMADedicatedCRRTdeviceBradykininReleaseSyndromeMucosalcongestion,bronchospasm,hypotensionatstartofCRRTResolveswithdiscontinuationofCRRTThoughttoberelatedtobradykininreleasewhenpatient’sbloodcontactshemofilterExquisitelypHsensitiveBradykininReleaseSyndromeMucBypassSystemtoPreventBradykininReleaseSyndromePRBCWasteBypassSystemtoPreventBradyRecirculationSystemtoPrev
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯系上傳者。文件的所有權益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網頁內容里面會有圖紙預覽,若沒有圖紙預覽就沒有圖紙。
- 4. 未經權益所有人同意不得將文件中的內容挪作商業或盈利用途。
- 5. 人人文庫網僅提供信息存儲空間,僅對用戶上傳內容的表現方式做保護處理,對用戶上傳分享的文檔內容本身不做任何修改或編輯,并不能對任何下載內容負責。
- 6. 下載文件中如有侵權或不適當內容,請與我們聯系,我們立即糾正。
- 7. 本站不保證下載資源的準確性、安全性和完整性, 同時也不承擔用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。
最新文檔
- 2025-2030年中國APET包裝盒行業現狀規模及投資發展動向研究報告
- 邢臺學院《國際文化貿易(雙語)》2023-2024學年第二學期期末試卷
- 2025-2030年中國DSD酸市場投資規劃及運營前景研究報告
- 甘肅省蘭州市名校2024年中考二模數學試題含解析
- 廣東省番禺區六校教育教聯合體2023-2024學年中考數學最后一模試卷含解析
- 2025安全管理人員安全培訓考試試題帶答案(培優)
- 2025年企業員工崗前安全培訓考試試題答案完整版
- 2025年日常安全培訓考試試題【考試直接用】
- 2024-2025生產經營負責人安全培訓考試試題答案突破訓練
- 2025新入職工入職安全培訓考試試題答案新
- 2025年建筑工程裝飾合同范本
- 2025-2030中國可再生能源行業發展分析及投資前景與戰略規劃研究報告
- 院校建設可行性研究報告
- 《電力設備典型消防規程》知識培訓
- 四川省成都東部新區龍云學校2024-2025學年五年級下冊半期測試題(含答案)
- 兒童支氣管哮喘診斷與防治指南(2025版)解讀課件
- 倉管員安全培訓課件
- 紅藍黃光治療皮膚病臨床應用專家共識解讀
- 區域健康醫療大數據中心建設方案
- 易制毒基礎知識試題及答案
- 人教版(PEP)五年級下冊英語期中測試卷 (含答案無聽力試題)
評論
0/150
提交評論